Metraipolis › archive › dc_60370fbf6702

Comparison of SGLT2 Inhibitors for New-Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function — Europe PMC PMID:41804189

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41804189
DOI
10.1111/dom.70625
License (as archived)
solo-consultazione
Archived
2026-11-05T00:24:15.210Z
SHA-256 of the archived text
2a46545026262f0b1f6e20a7fcf051d28b4fe262271b3a56b7bf61788e3f6bf2
Stable URL of this page
https://metraipolis.com/documento/dc_60370fbf6702

How to cite

Comparison of SGLT2 Inhibitors for New-Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function — Europe PMC PMID:41804189 — Europe PMC (en), https://europepmc.org/article/MED/41804189 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_60370fbf6702 (Metraipolis archive dc_60370fbf6702, sha256 2a46545026262f0b1f6e20a7fcf051d28b4fe262271b3a56b7bf61788e3f6bf2)
BibTeX
@misc{dc60370fbf6702,
  title = {Comparison of SGLT2 Inhibitors for New-Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function — Europe PMC PMID:41804189},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41804189},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_60370fbf6702; sha256 2a46545026262f0b1f6e20a7fcf051d28b4fe262271b3a56b7bf61788e3f6bf2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41804189. Agents can read the archived copy with the MCP tool read_document.